Join me as I evaluate the evolving treatment landscape, focusing on pharmaceutical interventions.

I will cover hot topics in the industry, including the rise and fall of blockbuster drugs. This includes clinical development, translation into clinical guidelines, and rollout into the community with approval and marketing efforts. I'll consider topics from all angles, including patients, healthcare professionals, regulatory agencies, and industry.

I have worked in medical communications for more than 15 years, collaborating with some of the brightest minds in the industry, and hearing first hand from patients, doctors, and industry representatives about what their unmet needs are and their ambitions. As new topics evolve, I will consider these perspectives, and share my own opinions.

I may focus somewhat on management of diabetes, obesity, and metabolic diseases, but I will not limit conversation to those diseases alone.

Thanks for your attention and support!